Consumables > Antibodies

The Native Antigen Company 2023 Southern Hemisphere flu season antigens

16 November, 2022

The Native Antigen Company has announced that haemagglutinin (HA) and neuraminidase (NA) antigens are now available to cover the 2023 Southern Hemisphere vaccine formulation.


Proteintech FlexAble antibody labelling kits

01 November, 2022

FlexAble from Proteintech is a novel antibody labelling kit for immunofluorescence (IF), western blot (WB) and flow cytometry (FC). The kits use an affinity linker to conjugate fluorochromes, enzymes and molecules to the user's chosen antibody in any buffer condition.


Antibodies from former COVID patients neutralise Delta, Omicron

23 September, 2022

Antibodies isolated from the immune system of recovered COVID-19 patients are effective in neutralising all known strains of the virus, including Delta and Omicron.


WHO strongly advises against antibody drugs to treat COVID-19

16 September, 2022

The antibody drugs sotrovimab and casirivimab-imdevimab are no longer recommended for patients with COVID-19.


ProSci poxvirus research tools

09 September, 2022

Many viruses in the Poxviridae family have genetic similarities, allowing many of the same research tools to be used on multiple viral species.


Bio-Rad Laboratories anti-evolocumab antibodies

29 August, 2022

The sequence-defined, recombinant antibodies are suitable for developing highly selective and sensitive pharmacokinetic (PK) and anti-drug antibody (ADA) assays for evolocumab and its biosimilars.


Abcalis Multiclonal Recombinant Secondary Antibodies

10 August, 2022

Multiclonals consist of defined mixtures of carefully selected individual recombinant monoclonal antibodies, recognising different epitopes on all four different subclasses of human IgG.


GeneTex ion channel antibodies

09 August, 2022

GeneTex offers a wide selection of antibodies to support ion channel research, with IHC-validated and/or ICC/IF-validated antibodies to facilitate research efforts in this field.


The Native Antigen Company monkeypox antigens

26 July, 2022

The Native Antigen Company has moved to develop a series of monkeypox antigens to support research into this disease.


Bio-Rad Laboratories anti-brentuximab vedotin and anti-secukinumab antibodies

14 July, 2022

The anti-brentuximab vedotin and anti-secukinumab inhibitory antibodies are available in Fab (fragment antigen-binding) and fully human IgG1 formats with different affinities.


HUABIO phospho-specific recombinant antibodies

07 July, 2022

Phospho-specific antibodies can be used to detect the phosphorylated form of the target protein by binding to the site-specific phosphorylated amino acid.


GeneTex vision and retina antibodies

06 July, 2022

GeneTex offers a large selection of antibodies for vision and retina research. It offers IHC-validated and/or ICC/IF-validated antibodies.


Absolute Antibody Prometheus antibody humanisation service

17 June, 2022

Absolute Antibody has expanded its Prometheus antibody humanisation service to offer humanisation from non-murine origin species, including rabbit antibodies and single-domain camelid nanobodies.


The Native Antigen Company human coronavirus antigens and antibodies

12 May, 2022

Native Antigen has rapidly expanded its range of SARS-CoV-2 recombinant antigens and antibodies.


'Mini antibodies' treat mice for inflammation

03 May, 2022

Normal antibodies provide additional stimulation to the immune system and can therefore exacerbate inflammation — a property that nanobodies lack.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd